Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -19,727 | N/A | N/A |
| Depreciation Amortization | 1,009 | N/A | N/A |
| Accounts payable and accrued liabilities | 434 | N/A | N/A |
| Other Working Capital | -795 | N/A | N/A |
| Other Operating Activity | 2,719 | 0 | 0 |
| Operating Cash Flow | $-16,360 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -2,876 | N/A | N/A |
| Investing Cash Flow | $-2,876 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 127,686 | N/A | N/A |
| Financing Cash Flow | $127,686 | $N/A | $N/A |
| Exchange Rate Effect | 561 | N/A | N/A |
| Beginning Cash Position | 28,059 | N/A | N/A |
| End Cash Position | 137,070 | N/A | N/A |
| Net Cash Flow | $109,011 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -16,360 | N/A | N/A |
| Capital Expenditure | -2,876 | N/A | N/A |
| Free Cash Flow | -19,236 | 0 | 0 |